Prescribing Information & Guidance
Recommendations on the use of Growth Hormone devices in children – Guidance Statement
Approved by BLMK APC March 2026
The BLMK Area Prescribing Committee (APC) agreed to support and ratify the updated East of England Advisory Committee EoEPAC) Guidance statement and recommendations on the use of growth hormone devices in children – see attached document for the full statement and recommendations.
The previous 2018 statement has now been archived.
Guideline Categories: Endocrinology and Diabetes
Guideline Areas: Bedfordshire, Luton, Milton Keynes
Guideline Tags: growth hormone, somapacitan, somatrogon, somatropin
Please use the search box to search the whole site if you can't find what you're looking for:
